Tracking extracellular matrix remodeling in lungs induced by breast cancer metastasis : Fourier transform infrared spectroscopic studies by Chrabąszcz, Karolina et al.
molecules
Article
Tracking Extracellular Matrix Remodeling in Lungs
Induced by Breast Cancer Metastasis. Fourier
Transform Infrared Spectroscopic Studies
Karolina Chrabaszcz 1,†, Katarzyna Kaminska 2,†, Karolina Augustyniak 1,
Monika Kujdowicz 1,3 , Marta Smeda 2, Agnieszka Jasztal 2, Marta Stojak 2,
Katarzyna M. Marzec 2 and Kamilla Malek 1,*
1 Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland;
karolina.chrabaszcz@doctoral.uj.edu.pl (K.C.); karolinakatarzyna.augustyniak@student.uj.edu.pl (K.A.);
monika.kujdowicz@uj.edu.pl (M.K.)
2 Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, 30-384 Krakow, Poland;
katarzyna1.kaminska@uj.edu.pl (K.K.); marta.wojewoda@jcet.eu (M.S.); agnieszka.jasztal@jcet.eu (A.J.);
marta.stojak@jcet.eu (M.S.); katarzyna.marzec@jcet.eu (K.M.M.)
3 Department of Pathology, Medical Faculty, Jagiellonian University Medical College, 31-531 Krakow, Poland
* Correspondence: kamilla.malek@uj.edu.pl
† Both authors should be considered as first authors.
Academic Editor: Kamilla Malek
Received: 9 December 2019; Accepted: 3 January 2020; Published: 6 January 2020


Abstract: This work focused on a detailed assessment of lung tissue affected by metastasis of breast
cancer. We used large-area chemical scanning implemented in Fourier transform infrared (FTIR)
spectroscopic imaging supported with classical histological and morphological characterization. For
the first time, we differentiated and defined biochemical changes due to metastasis observed in the
lung parenchyma, atelectasis, fibrous, and muscle cells, as well as bronchi ciliate cells, in a qualitative
and semi-quantitative manner based on spectral features. The results suggested that systematic
extracellular matrix remodeling with the progress of the metastasis process evoked a decrease in the
fraction of the total protein in atelectasis, fibrous, and muscle cells, as well as an increase of fibrillar
proteins in the parenchyma. We also detected alterations in the secondary conformations of proteins
in parenchyma and atelectasis and changes in the level of hydroxyproline residues and carbohydrate
moieties in the parenchyma. The results indicate the usability of FTIR spectroscopy as a tool for
the detection of extracellular matrix remodeling, thereby enabling the prediction of pre-metastatic
niche formation.
Keywords: FTIR imaging; extracellular matrix remodeling; fibrous proteins; cancer metastases
1. Introduction
Cancer malignant behavior can be terminal. Tumors can spread into organs and invade nearby and
further tissues. The leading cause of death in advanced stages of cancer is metastasis formation and its
consequences [1]. Several steps define metastasis. It starts from biochemical changes in the cancer cells
and primary tumor niche, the production of chemokines, immune system reactions, and the destruction
of healthy tissues by enzymes. Then the cancer process encompasses the whole body. The subsequent
metastatic steps include intravasation into the blood and lymphatic vessels, transport, extravasation
into distant sites, and colonization to form micrometastases and macrometastases [1,2]. Despite the
rapid development of diagnostic techniques, particularly radiology (e.g., magnetic resonance imaging,
positron emission tomography, X-ray), cytology, histopathology, and molecular methods, sensitivity in
the detection of micrometastases and defining the pre-metastatic niche is not sufficient.
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Recent studies have also introduced the concept of the pre-metastatic niche. This is the formation
of a specialized microenvironment through extracellular matrix remodeling, immunosuppression,
inflammation, and vascular hyperpermeability, created by the primary tumors in secondary organs and
tissue sites for subsequent metastases [3,4]. Therefore, the characterization of the metastatic process
before micrometastases formation is vital to supporting appropriate treatment and to decrease the
cancer-related death rate.
Cancer-related processes transform several tissue structures [5,6]. Abnormal changes were found
in the amount and composition of the extracellular matrix (ECM) in the primary tumor tissue and
metastasis places, particularly in the lungs [6]. ECM remodeling is directly linked to tumor progression
in the lungs [7]. ECM is a three-dimensional, non-cellular macromolecular network composed of three
major components: proteins, glycosaminoglycans, and glycoconjugates. Changes in ECM architecture
are always present during cancer development [7,8]. The remodeling process is associated with
interactions between components of the cellular microenvironment such as hyaluronan, fibronectin [9],
tenascin-C [10], laminin-322 [11], thrombospondin-1 [12], and collagens [9]. These proteins directly
regulate the cellular functions, growth, differentiation, adhesion, migration, invasion, and colonization
of cancer cells [9]. Furthermore, they can create a favorable environment for tumor survival that leads
to disorders of tissue function.
Owing to the complicated mechanisms of ECM-cancer interactions, the remodeling process
requires the application of sensitive and non-destructive methods. This is required to recognize not
only its impact on the chemical composition of the entire tissue but also to define tissue sub-structures
and their distribution within lung parenchyma. Fourier transform infrared (FTIR) spectroscopy is
one of the techniques that allow the determination of a panel of biochemical changes occurring in
tissue using a specific pattern of IR bands attributed to the most significant biological components
such as proteins, lipids, carbohydrates, and nucleic acids. This method was successfully applied in the
discrimination of healthy tissues from advanced cancer at various organs, collected as biopsies from
clinical patients. The most prominent changes caused by cancer development in the breast [13] and
esophagus [14] were an increase in lipids (2800–3000 cm−1) and DNA IR absorptions (1090–1080 cm−1)
accompanied by an intensity decrease in the protein range (1800–1500 cm−1). In turn, studies of lung
cancer via FTIR spectroscopy were conducted to establish the differences between cancerous and
healthy lung tissue samples [15]; to investigate the spectral profile of malignant, adjacent to cancer,
and healthy lung tissue [16]; to classify lung adenocarcinoma and its degree of malignancy [17]; to
detect lung cancer from sputum samples [18].
To the best of our knowledge, no report in the literature investigates in detail the spectral and
chemical transformations in the extracellular matrix due to cancer and metastasis progression using
FTIR spectroscopy. Our previous studies, employing infrared spectroscopic imaging as the primary
analytical tool, showed global chemical changes appearing during the neoplastic process in the lung
due to metastasis from breast adenocarcinoma and identified small clusters of cancer cells settled
in various lung environments [19]. Moreover, it was possible to identify the type of metastases, i.e.,
the attack of cancer cells through blood vessels or pleura, and to provide insight into their spectral
heterogeneity [20]. We also provided FTIR-based discrimination of the early- and late-phases of cancer
and metastasis development in blood plasma [21].
A few reports already showed the ability of FTIR spectroscopy to investigate protein structures
(mainly collagen) and their changes in tissues induced by remodeling. For instance, a brain tumor can
be discriminated from healthy tissue by the relative contribution of triple helices, β-sheets, and β-turns.
The triple helix absorption at 1637 cm−1 was proposed as the indicator of collagen contents, but no
intensity changes in this band were found in healthy, solid tumor, and diffuse tumor tissues [22,23].
Next, extracellular matrix remodeling was characterized spectroscopically by Bromberg and co-workers
in the cardiomyopathic Syrian hamster heart [24]. The IR profile of healthy cardiac tissue differed
from myocardial dysfunction in the collagen spectral region. In particular, decreased intensities of
the amide III (1335–1201 cm−1), C-O carbohydrate residues bands (1031 and 1081 cm−1), as well as a
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lower ratio of the 1162 and 1172 cm−1 bands (C-OH stretches of hydroxyproline) were observed in the
cardiomyopathic tissue. Another process, associated with extracellular component degradation, is
fibrosis [25]. This process occurs as the final pathway of tissue damage in that mainly collagen I, III,
and IV are degraded. Rapid quantum cascade laser IR (QCL-IR) imaging of renal transplant biopsies
identified progressive fibrosis via determination of the intensity ratio of bands at 1035 and 1079 cm−1,
assigned to collagen associated carbohydrate moieties (C–O and C–O–C stretches, respectively) [25].
The invasion of cancer cells in lung tissue and the formation of the pre-metastases niche is
connected with changes in the structure and composition of fibrillar proteins, the main components of
ECM [26,27]. Studies reporting investigations of this process indicated that there is a lack of tools to
identify and predict the pre-metastatic niche formation, including ECM remodeling [28]. Therefore, to
assess extracellular matrix remodeling caused by 4T1 breast cancer metastasis to the lung, we employed
IR imaging, which permits the interrogation of tissue biochemistry with spatial information. The latter
is an ex vivo orthotopic mouse model in which 4T1 breast cancer cells are injected into the mammary
gland where the tumor grows and then metastases to the lungs within 2–3 weeks [29,30]. Our previous
experiments showed how difficult it is to detect metastases in the very early phases of the disease
based only on medical parameters such as lung weight, primary tumor volume, and the number of
pulmonary metastases [29,30]. Here, we show the progression of chemical changes in lung regions
not directly affected by the presence of secondary tumors within five weeks of the pulmonary breast
cancer metastasis. We demonstrated, for the first time, utilization of FTIR spectroscopic imaging to
study different fractions of the extracellular matrix to understand the process of the metastatic niche
and provide the characteristics of remodeling in the lungs affected by metastasis.
2. Results and Discussion
2.1. Morphological Characterization of Lungs in Metastasis Development
The development of lung metastases was examined between the first and fifth weeks after cancer
cell injection into the mammary gland, and it was compared to healthy control. A schematic presented
in Figure S1 in Supplementary Materials reflects the main morphological and biochemical changes
occurring in mice lungs during the pulmonary breast cancer progression in this specific animal cancer
model [29–33].
According to hematoxylin and eosin (H&E) staining, the lungs on week 1 after 4T1 cells inoculation
did not differ from the healthy control (Figure 1). In the early pre-metastatic phase (week 2), the lungs
displayed histopathological signs of inflammation caused by granulocyte infiltration (Figure 1). In
the third week, a single cancer cell or up to 10 cell clusters occurred in the lungs. No metastases or a
maximum of two metastases per animal were observed under such conditions in the whole left lung
(Table 1). In this phase, the weight of lungs slightly increased while a mass of the primary tumor in
the breast increased tenfold (Table 1). Owing to further metastasis progression, we observed large,
clear-cut metastatic foci in the lungs and visible scattered macrometastases. These occupied the lung
parenchyma and were also found under the pleura (week 4, Table 1). In the last phase (week 5),
the lungs were occupied by very advanced macrometastases of different sizes. Between 7 and 89
metastases were observed in the lungs of mice studied at this stage of the cancer progression (Table 1).
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Figure 1. Comparison of false-color unsupervised hierarchical cluster analysis (UHCA) maps with 
hematoxylin and eosin (H&E) microphotographs collected from lung cross-sections. UHCA 
classification of the most abundant tissue types in lungs: parenchyma (grey), atelectasis (green), 
fibrous/muscular tissue (blue), and bronchi ciliated cells (aqua) corresponds to tissue structure 
observed in the H&E images. Magnified microphotographs after H&E staining with marked tissue 
types are shown in Figure S2 in Supplementary Materials. 
  
Figure 1. Comparison of false-color unsupervised hierarchical cluster analysis (UHCA) maps
with hematoxylin and eosin (H&E) microphotographs collected from lung cross-sections. UHCA
classification of the most abundant tissue types in lungs: parenchyma (grey), atelectasis (green),
fibrous/muscular tissue (blue), and bronchi ciliated cells (aqua) corresponds to tissue structure observed
in the H&E images. Magnified microphotographs after H&E staining with marked tissue types are
shown in Figure S2 in Supplementary Materials.
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Table 1. The number of metastases, lung weight expressed as a percentage of body weight, and primary
tumor mass in the 4T1 metastatic breast cancer model (N = 3 animals per experimental group).
Group Number of Metastasis Lungs Mass [% of Body Weight] Primary Tumor Mass [g]
control 0 0.795–0.894 0
week 1 0 0.785–0.903 0
week 2 0 0.731–0.8 0–0.024
week 3 0–2 0.82–0.84 0.203–0.257
week 4 2–5 0.75–0.895 0.493–0.700
week 5 7–89 0.827–0.986 0.927–2.562
Lung lobes, in which no metastases were detected, were selected in this work to evaluate the
remodeling of their morphology and biochemistry (Figure 1). We excluded tissue cross-sections with
secondary tumors to avoid the effect of tumor metabolism on the surrounding lung cells. As shown
in Figure 1, we assessed EMC in four types of tissue morphology typical for lungs, i.e., the main
component of the lung, parenchyma. It is transformed into atelectasis in the late phase, as well as
fibrous and muscle cells merged, and bronchi ciliated cells.
Normal lung parenchyma consists of airways and thin-walled alveoli (Figure 1 and Figure S2
in Supplementary Materials, gray class). The alveoli are composed of a single layer of squamous
epithelium and are lined almost exclusively by type I and II pneumocytes. A thin layer of connective
tissue and numerous capillaries can also appear between the alveoli structures. Pneumocytes type 2
produces surfactant which is stored in structures called lamellar bodies, and they release surfactant
into the alveoli. Under normal conditions, a few alveolar macrophages trundle around the alveoli
scavenging for debris that was not removed by the mucociliary apparatus.
Atelectasis of lung parenchyma results from the collapse of a part of the lung due to a decrease in
the amount of air in the alveoli (Figure 1 and Figure S2 in Supplementary Materials, green class). The
pathologist recognized the first signs of atelectasis in the lung parenchyma as already being in the
control tissue. Atelectasis could occur in the control animals as a result of the collapse of the part of
the lung due to inflammation caused by a factor different from cancer cells. In the second week, the
atelectasis of lung parenchyma was more advanced. A visual inspection of the macro-metastatic phases
(weeks 3 and 4) suggested that the atelectatic changes were similar. In the fifth week, the atelectasis
occupied almost the entire cross-sections of the lung (Figure 1 and Figure S2 in Supplementary
Materials). As expected, the increase of the atelectasis area was associated with an increase in lung
weight (Table 1).
Airways are surrounded by connective tissue consisting of fibers, ground substance, and cells.
This tissue contains bronchial arteries, venous trunks, lymphatics, and nerves. In the airways, smooth
muscles are found in many structures. Thus, fibrous and muscular tissue mainly surround blood
vessels and large bronchioles in the lung lobes (Figure 1 and Figure S2 in Supplementary Materials).
The trachealis smooth muscle bridges the gap between the free ends of C-shaped cartilages at the
posterior border of the trachea. Every single bronchiole has a complete fibromuscular wall with the
muscle arranged in a spiral, while smaller bronchi possess only smooth muscle fibers. The tunica
media of the pulmonary veins is constituted by cross-striated muscle tissue, which consists mostly of
actin filaments in association with myosin [34]. Larger elastic pulmonary arteries are composed of
multiple layers of the elastic lamina and smooth muscle cells. In our study, fibrous and muscle tissue
was merged into one class (Figure 1, blue class) [5,35]. Damage of lung parenchyma caused by cancer
progression may cause pulmonary fibrosis. This process is characterized by the accumulation of excess
fibrous connective tissue which leads to changes in the normal architecture and function of the tissue.
The increase in fibrous and muscle tissue in this study was observed in the fourth and fifth weeks after
cancer cell inclusion.
The surface epithelium of bronchi and bronchioles contains two principal cell types: ciliated and
secretory cells. Secretory cells based on their microscopic appearance can be divided into subtypes
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called Clara, goblet, and serous cells. In turn, the bronchi ciliated cells are formed by the congregation
of microtubules associated with dynein arms to form axonemes of mobile cilia (Figure 1 and Figure S2
in Supplementary Materials) [36]. In our study, this class did not change with cancer progression.
2.2. FTIR-Based Discrimination of Chemical Changes in Lung Tissue Structures due to Metastasis
With the use of FTIR spectroscopic imaging with a pixel size of 5.5 µm2, we collected chemical
images of entire lung cross-sections. Since we collected a large spectral database (Table S1 in
Supplementary Materials), we employed unsupervised hierarchical cluster analysis (UHCA) to
differentiate tissue cross-sections into four assigned to the cell phenotypes described above (Figure 1
and Figure S3 in Supplementary Materials). Figure 2 shows the mean second derivative IR spectra
extracted from the UHCA analysis from the corresponding classes of the cell phenotypes. The
assignment of the UHCA classes to the cells was confirmed by the examination of lung morphology
revealed by the H&E staining (Figure 1). Bands assignment observed in the fingerprint region of the IR
spectrum is summarized in Table 2.
Table 2. An assignment of the major bands of Fourier transform infrared (FTIR) spectra depicted in
Figure 2 [14,22–25].
Vibration Modes Position [cm−1] Assignment
ν(C=O), amide I: β-turns, β-sheets 1684, 1680 Proteins
ν(C=O), amide I: α-helices 1655, 1652 Proteins
ν(C=O); amide I, parallel β-sheets 1631, 1628 Proteins
δ(NH); amide II of proteins 1547 Proteins
in-plane δ(CH) of phenyl ring 1516 Tyrosine residues
ν(C-N)/δ(N-H)/ν(CH3-C): amide III 1310, 1312 Proteins
amide III 1286–1202 Fibrous proteins
ν(C-OH) 1166 Hydroxyproline residues
ν(C-O), δ(C-O-H), δ(C-O-C) 1116, 1081, 1038 Collagen-associated carbohydrate moieties
Alternation of intensity and shape of bands in the region of 1700–1485 cm−1, which were attributed
to amide I and II vibrations of proteins, indicated changes in the secondary conformations of proteins.
Apart from the 1655 cm−1 band assigned to α-helical secondary structures, the IR spectra of lung
parenchyma and bronchi ciliated cells, which sweep small particles polluted bronchi, showed an
increase in intensity at ca. 1630 cm−1 due to metastasis progression. This spectral feature was
pronounced in the phase when the cancer cells clustered into large macrometastases, week 4 in
Figure 2(1A,B). Macrometastases can obstruct bronchi (from tissue pressure or intrabronchial mass)
leading to hindered airflow and damaged ciliated cells. In addition, the IR spectra of parenchyma
exhibited variations in the position and shape of the spectral region below 1670 cm−1. The red-shift of
the band at 1655 cm−1 by 3 cm−1 was observed bearing large metastatic nodules. This outcome suggests
that proteins in the extracellular matrix of the lung parenchyma underwent proteolysis leading to the
formation of β-sheet and β-turn conformations and the unwinding of collagen triple-helices [37]. In
turn, atelectasis and fibrous/muscular structures did not show visible spectral changes in the amide
I and II regions due to intravasation of the cancer cells to the lungs (Figure 2(1C,D)). In the case of
fibrous/muscular tissue, the ca. 1630 cm−1 band was absent.
The most pronounced spectral changes associated with the ECM remodeling process were found
in the region below 1400 cm−1 (Figure 2(2A–D)). Here, we observed bands attributed to the amide
III mode of lung fibrillar proteins such as collagens [23], elastins [38], fibrillins, actins, and myosin
(at ca. 1205, 1235, ca. 1280, ca. 1310, and 1318 cm−1) and glycoprotein- and collagen-associated
carbohydrate moieties (at 1031 and 1081 cm−1), c.f. Table 2. Even though it is impossible to assign
amide III bands to particular fibrillar proteins, the spectral changes in this region can indicate the
remodeling of the extracellular matrix due to the expected degradation of elastin fibers and the
action of metalloproteinases (MMP) degrading fibrillar proteins [30]. A visual examination of the IR
Molecules 2020, 25, 236 7 of 14
spectra of the parenchyma and atelectasis classes showed the disappearance of the 1277 cm−1 band,
contrary to the bronchi ciliated cells in that this band which was blue-shifted to 1286 cm−1 during the
metastasis progression (Figure 2(2)). For atelectasis and fibrous tissue, this band remained unchanged
in comparison to the control. The intensity of the bands at ca. 1205 cm−1 decreased in all investigated
types of lung tissue due to the metastasis progression, except for the fibrous and muscular class
(Figure 2(2)).
Molecules 2020, 25, 236 6 of 14 
of microtubules associated with dynein arms to form axonemes of mobile cilia (Figures 1 and S2 in 
Supplementary Materials) [36]. In our study, this class did not change with cancer progression. 
2.2. FTIR-Based Discrimination of Chemical Changes in Lung Tissue Structures due to Metastasis 
With the use of FTIR spectroscopic imaging with a pixel size of 5.5 µm2, we collected chemical 
images of entire lung cross-sections. Since we collected a large spectral database (Table S1 in 
Supplementary Materials), we employed unsupervised hierarchical cluster analysis (UHCA) to 
differentiate tissue cross-sections into four assigned to the cell phenotypes described above (Figures 
1 and S3 in Supplementary Materials). Figure 2 shows the mean second derivative IR spectra 
extracted from the UHCA analysis from the corresponding classes of the cell phenotypes. The 
assignment of the UHCA classes to the cells was confirmed by the examination of lung morphology 
revealed by the H&E staining (Figure 1). Bands assignment observed in the fingerprint region of the 
IR spectrum is summarized in Table 2. 
 
Figure 2. The comparison of second derivative IR spectra extracted from UHCA analysis for lung 
parenchyma (averaged from n = 37 spectra) (A), bronchi ciliated cells (averaged from n = 23 spectra) 
Figure 2. c i f s c eri ti I s ectr extr ct fro analysis for lung
parenchy a (averaged fro n = s ctr ) ( ), bronc i ciliate cel s (average fro n = s t )
(B), atelectasis (averaged from n = 43 spectra), (C) and fibrous/muscular tissue (averaged from n = 44
spectra) (D). Spectra are shown in the regions of 1700–1480 (1) and 1340–1000 cm−1 (2). On week 5,
bronchi ciliated cells were not found since atelectasis covers the entire area of the lungs.
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2.3. A Semi-Quantitative FTIR Approach in an Analysis of Proteins in the Lung Tissue Structures
In the semi-quantitative analysis, which gives a trend of molecular composition variation
throughout metastasis development, we computed the integral intensities of the discussed-above
bands for the classes of the lung parenchyma, atelectasis, fibrous, and muscular tissue since they
represented the major components of the extracellular matrix (Figure 3).
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The intensity sum of the amide I and II bands allowed the monitoring of changes in the total
content of proteins (total proteins in Figure 3). Even though we observed changes in the secondary
structures of proteins in the lung parenchyma, the content of proteins was constant for all phases in the
disease progression (data not shown). Atelectasis, as well as fibrous/muscular tissue, significantly lost
proteins in their chemical composition along with development of the first metastatic nodules in the
lungs (week 3) and this process was continued till the macrometastatic phase (week 5) indicating that
the proteolysis of proteins in the lung cells resulted from tumor metabolism (Figure 3A,B) [39]. An
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immunochemical analysis employed in a previous study on this cancer model assessed the expression of
elastin and metalloproteinases MMP-2, MMP-4, and MMP-9 in the lung and it showed the degradation
of elastin and increased expression of MMPs on weeks 3 and 4, respectively [30]. This result suggested
that the intensities of amide I and II highlighted the degradation of proteins in the lungs, pointing out
that this process was more advanced in dense structures of the tissue than in thin-walled alveoli.
To investigate changes in the secondary structures of proteins, a ratio of amide II to amide I was
calculated (secondary structure of proteins in Figure 3). In this case, no changes were found in the
class of fibrous and muscular tissue (data not shown) as expected from the visual inspection of its IR
spectra. Generally, the trend of changes was similar for both the lung parenchyma and atelectasis
(Figure 3C,D). A significant decrease of the amide II to amide I ratio was observed in the first week
after 4T1 cell transplantation for the atelectasis tissue, even though H&E staining did not indicate any
morphological differences between this time point (week 1) and the healthy control. Afterward, the
process of protein remodeling was gradually enhanced until the macrometastatic phase, indicating
the disturbance of tissue homeostasis. This process could be related to the formation of amyloid-like
structures. This observation was congruent with the appearance of the shoulder at 1628 cm−1 in the
secondary derivative IR spectra, as discussed above (Figure 2(1A,C)). Amyloid fibrils are formed from
cross-β polymerization of β-pleated sheets, and it has been observed in various types of cancer [40].
Some reports discussing this issue showed that a large number of amyloid proteins were stored in
dormant cancer cells and the amyloid-β precursor protein was engaged in cell adhesion molecules to
bind with the ECM components [41]. Since the metastatic 4T1 cells used in this work also exhibited a
high expression of the amyloid-β precursor protein, we hypothesized here that the observed changes
in the secondary conformations of proteins could be associated with such transformation of these
macromolecules [30,42]. Interestingly, we showed the elevated formation of β-sheets in the FTIR
spectra of murine plasma derived from the same animal experiment [21]. Indeed, similar observations
in the lung and plasma suggested that the IR spectra of blood plasma reflected processes of matrix
remodeling in the metastatic lung.
The most prominent markers for evaluating extracellular remodeling are amide III bands assigned
to fibrillar proteins (ca. 1281, 1235, and 1205 cm−1) [23]. Graphs in Figure 3E–G show various spectral
responses in the content of these proteins in the selected lung morphological structures of 4T1 breast
cancer-bearing mice. Local deposition of fibrillar proteins in the lung parenchyma began at the
micrometastasis stage (week 3) and exhibited the highest level for lungs with advanced metastases
(week 5), see Figure 3E. According to Bromberg and co-workers [24], we explicitly correlated this
funding to collagen remodeling in the extracellular matrix. This was because other spectral markers of
collagens, i.e., at 1166 cm−1 (hydroxyproline residues) and in the region of 1137–1015 cm−1 (carbohydrate
moieties), showed trends of changes similar to the region of the amide III bands (Figure 3H,J). The
class of atelectasis with features of fibrotic structure exhibited variations in the intensity of the amide
III bands (Figure 3F). In the early stage, in the first week of cancer cell transplantation, there was a
mild deposition of fibrillar proteins that was maintained until the terminal phase of cancer progression.
Since no intensity changes were found for the two collagen bands below 1200 cm−1, the observed
immunochemical degradation of elastin and the activity of the MMPs could be reflected by the spectral
variation in the amide I, II, and III regions of the lung atelectasis [30]. Fibrous and muscular tissue
surrounds blood vessels and large bronchioles and it is composed of collagenous fibers and actin
filaments, where it showed a decrease of fibrillar proteins in the pre- and early-metastasis stage (week
2 and week 3), contrary to the remaining cancerous phases (Figure 3G). This result could suggest that
the IR spectra of this lung structure indicated remodeling of the vascular walls due to their enhanced
permeability for cancer cells circulating in the blood system at the early phase of cancer metastasis [43].
This process must be accompanied by the structural deformation of proteins around the hydroxyproline
residues, which gradually occurs in the pre-metastatic phase, see graph in Figure 3I.
Finally, we correlated the spectral parameters extracted from each cross-section to a mass of the
lungs in the investigated animals using the Spearman correlation test (Table 3). The Spearman’s rank
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correlation coefficients (R), as well as values of probability (P), suggested that the observed molecular
changes in structure and composition of the lung proteins may correlate with physical changes of the
metastatic organ. Further investigations on a more extensive set of samples must be performed.
Table 3. The correlation between the lung-to-body weight ratio [%] and selected FTIR biomarkers
associated using the Spearman’s rank correlation coefficient (R) and probability (P).
Spectral Parameter Lungs Mass [% of Body Weight]
Spearman R Spearman P
PARENCHYMA
Secondary structure of proteins 0.82 0.001
Fibrillar proteins 0.81 0.001
Carbohydrates moiety 0.81 0.001
Hydroxyproline residues 0.84 0.0006
ATELECTASIS
Total proteins 0.84 0.0006
Secondary structure of proteins 0.88 0.0002
FIBROUS/MUSCULAR
Total proteins 0.87 0.0002
Fibrillar proteins 0.82 0.001
Hydroxyproline residues 0.82 0.0009
3. Materials and Methods
3.1. Sample Preparation and Histological Analysis
Lung tissue samples were taken from inbred mouse strains BALB/cAnNCrl (control) and
BALB/cAnNCrl within five weeks (weeks 1, 2, 3, 4, and 5) after orthotopic inoculation with viable
4T1 tumor cells of metastatic breast cancer. In total, six experimental groups (N = 18 animals in total,
N = 3 per each group). Isolated lungs were washed in saline and fixed with 4% formalin buffered
solution for 48 h. Paraffin-embedded cross-sections of tissues were cut from the middle of the isolated
left lung (Table S1 in ESI). Then, 7 µm-thick cross-sections were prepared using a paraffin method
on an Accu-Cut® SRM™ 200 Rotary microtome mounted on CaF2 windows and dewaxed before
FTIR imaging. This fixation method optimally preserves the structure of the tissue required for
histological analysis by blocking autolysis and by crosslinking the amine groups of proteins. Despite
the impact of the fixative agent on the tissue component, these alternations were smaller than the
molecular changes associated with disease and did not affect spectral differentiation [44,45]. After
the collection of the FTIR images, the same sections were stained with hematoxylin and eosin (H&E)
for gold-standard histopathological examination. Digitized photographs were taken from the H&E
slides. The examination and photographic documentation were performed using an Olympus BX53F
white-light microscopic equipped with a DP74 digital camera. All investigations presented in this
work conformed to the Guide for Care and Use of Laboratory Animals published by the US National
Institutes of Health. A local animal research committee approved the experimental procedures used in
the present study (permit no. LKE140/2013).
3.2. An Assessment of the Primary Tumor, Number, and Type of Metastases in the Lungs
Primary tumors were carefully dissected from the surrounding tissue and weighed. Isolated lungs
were washed in saline, weighed, and fixed with 4% formalin buffered solution. To count the number
of metastatic sites, we cut the lungs into lobes and the pulmonary metastases were counted on the
surface of the lung lobes under a magnifying glass.
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3.3. FTIR Spectroscopic Imaging and Data Analysis
We used a combination of an Agilent 670-IR FTIR spectrometer and a 620-IR microscope working
in rapid mode, which allows for the collection of 16,384 spectra from an area of ca. 495,616 µm2 within
90 s (Santa Clara, CA, USA). A focal plane array (FPA) detector cooled with liquid nitrogen was coupled
with this equipment. The detector consisted of a matrix of 16,384 pixels, arranged in a 128 × 128 grid
format. The collection of IR images was performed in transmission mode. FTIR spectroscopic imaging
used a 15× Cassegrain objective and condenser optics with NA of 0.62 and a projected FPA pixel size
of 5.5 µm × 5.5 µm, giving a measured area of ca. 704 µm × 704 µm. All FTIR spectra were recorded by
co-adding of 64 scans and in the range of 3800 to 900 cm−1 with a spectral resolution of 8 cm−1.
Pre-processing of the FTIR spectra and chemometric analysis were performed using CytoSpec (ver.
2.00.01) [31], MatLab (R2015a, Natick, MA, USA), and Origin 9.1 (ver. 2018b, OriginLab, Northampton,
MA, USA) software. Firstly, a quality test was employed to introduce a threshold level and to eliminate
signals with an absorbance lower than 0.2 and greater than 1.2. This operation was performed in
the region between 1620 and 1680 cm−1. To remove spectral noise, we executed PCA-based noise
reduction with 15 PCs. Resonant Mie scattering EMSC correction using seven principal components
was performed on all spectra [32]. Next, second derivative IR spectra were calculated with 9 smoothing
points according to the Savitzky–Golay protocol. All spectra were then vector normalized in the 914 to
1770 cm−1 region to avoid differentiation to the sample thickness. Unsupervised hierarchical cluster
analysis (UHCA) was executed in the spectral region of 970 to 1770 cm−1 using the second derivative
FTIR spectra. Spectral distances were computed as D-values and the individual clusters were extracted
according to Ward’s algorithm. Four classes were selected to differentiate the tissue types of interest.
Mean second derivative spectra were used for the calculation of the integral intensity of various
bands using the OPUS 7.0 program (Bruker Optics, Bullerica, MA, USA, Version 7.2.139.1294). For
this purpose, a linear baseline was drawn through the peak edges, and the spectrum below this line
was integrated over the wavenumber range of the band. Box plots were constructed for an analysis of
variance performed using the statistical model (ANOVA) in the OriginPro 9.1 software. Tukey’s test
was employed to compute significance values p. The correlation between the lung-to-body weight
ratio [%] and selected FTIR biomarkers was performed via the Spearman’s rank correlation coefficient
(R) and probability (P) in SPSS Statistics 24 (IBM Corporation, New York, NY, USA) software.
4. Conclusions
This study comprehensively described changes in proteins of the extracellular matrix in the lungs
as being the primary site of metastasis in the mice model of breast cancer. Using large-area scanning
implemented in FTIR spectroscopic imaging indicated molecular changes across whole cross-sections
of the lungs giving insight into the separated tissue structures. We found that using FTIR spectroscopy;
we obtained the biochemical information that allowed us to differentiate not only the type but also the
degree of protein degradation. The spectral changes that appeared in lung parenchyma and atelectasis
indicated a significant variation in secondary conformations of proteins and their composition. The
former appeared similarly in both main constituents of the lung but the deposition of fibrillar proteins
was specific for each of them. These alternations occurred before the invasion of breast cancer cells to
the lungs suggesting that the amide I–III regions in the IR spectrum were sensitive to the signaling of
the primary tumor. Consequently, this highlighted inflammation of the lung due to the transplantation
of breast cancer cells recognized by H&E staining in the early phase and/or the formation of the ECM
environment suitable for settling metastatic cancer cells.
Supplementary Materials: The following are available online, Table S1. Summary of collected data from N
= 3 mice/group. Figure S1. A schematic of the investigated phases of pulmonary breast cancer metastasis.
Development of lung inflammation and metastases were examined from week 1 to week 5 following 4T1 cancer
cells transplantation. Figure S2. H&E microphotographs (20x) showing cellular phenotypes of lung parenchyma
observed in healthy control (A) and advanced macrometastasis (B). Figure S3. UHCA clustering of the measured
IR images of the lung cross-sections into parenchyma (grey), atelectasis (green), fibrous/muscular (blue), and
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bronchi ciliated cells (aqua) for pulmonary metastasis of breast cancer compared to the healthy control; weeks 1
and 2–the pre-metastatic phase, week 3–the early micrometastatic stage, week 4–the advanced micrometastatic
phase, and week 5–the advanced macrometastatic stage. For more information about the FTIR imaged area of
tissues and collected spectra, see Table 1.
Author Contributions: Conceptualization, K.M.; methodology, K.M., K.C.; data collection, K.C., K.A.; spectral
and histological analysis, K.C., K.K., K.A., and M.K.; animal studies and samples preparation, M.S., A.J.; first draft
preparation, K.C., K.K., K.A.; writing—review and editing, K.M., M.K., and K.M.M.; visualization, K.C., K.K.,
K.A.; supervision, K.M.; project administration, K.M.; funding acquisition, K.M. All authors have read and agreed
to the published version of the manuscript.
Funding: This research was funded by the National Science Centre, Poland (UMO 2016/23/B/NZ4/01379).
Acknowledgments: K.M.: K.K., K.C., and K.A. thank the National Science Centre, Poland (UMO
2016/23/B/NZ4/01379) for financial support of the research. K.M.M. would like to acknowledge the support from
the Polish Ministry of Science and Higher Education (grant No. IP2015 048474).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Klein, C.A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 2009, 9, 302–312.
[CrossRef]
2. Weigelt, B.; Peterse, J.L.; van ’t Veer, L.J. Breast cancer metastasis: Markers and models. Nat. Rev. Cancer
2005, 5, 591–602. [CrossRef]
3. Peinado, H.; Lavotshkin, S.; Lyden, D. The secreted factors responsible for pre-metastatic niche formation:
Old sayings and new thoughts. Semin. Cancer Biol. 2011, 21, 139–146. [CrossRef]
4. Alderton, G.K. Metastasis. Exosomes drive premetastatic niche formation. Nat. Rev. Cancer 2012, 12, 447.
[CrossRef]
5. Murata, T. Histological Studies on the Respiratory Portions of the Lungs of Cetacea. Sci. Rep. 1951, 6, 35–47.
6. Lu, P.; Weaver, V.M.; Werb, Z. The extracellular matrix: A dynamic niche in cancer progression. J. Cell Biol.
2012, 196, 395–406. [CrossRef]
7. Dunsmore, S.E.; Rannels, D.E. Extracellular matrix biology in the lung. Am. J. Physiol. 1996, 270, 3–27.
[CrossRef]
8. Theocharis, A.D.; Skandalis, S.S.; Gialeli, C.; Karamanos, N.K. Extracellular matrix structure. Adv. Drug
Deliv. Rev. 2016, 97, 4–27. [CrossRef]
9. Xiong, G.; Flynn, T.J.; Chen, J.; Trinkle, C.; Xu, R. Development of an ex vivo breast cancer lung colonization
model utilizing a decellularized lung matrix. Integr. Biol. 2015, 7, 1518–1525. [CrossRef]
10. Oskarsson, T.; Acharyya, S.; Zhang, X.H.; Vanharanta, S.; Tavazoie, S.F.; Morris, P.G.; Downey, R.J.;
Manova-Todorova, K.; Brogi, E.; Massagué, J. Breast cancer cells produce tenascin C as a metastatic niche
component to colonize the lungs. Nat. Med. 2011, 17, 867–874. [CrossRef]
11. Malanchi, I.; Santamaria-Martínez, A.; Susanto, E.; Peng, H.; Lehr, H.A.; Delaloye, J.F.; Huelsken, J. Interactions
between cancer stem cells and their niche govern metastatic colonization. Nature 2011, 481, 85–89. [CrossRef]
12. Bissell, M.J.; Weaver, V.M.; Lelièvre, S.A.; Wang, F.; Petersen, O.W.; Schmeichel, K.L. Tissue structure, nuclear
organization, and gene expression in normal and malignant breast. Cancer Res. 1999, 59, 1757–1763.
13. Depciuch, J.; Kaznowska, E.; Golowski, S.; Koziorowska, A.; Zawlik, I.; Cholewa, M.; Szmuc, K.; Cebulski, J.
Monitoring breast cancer treatment using a Fourier transform infrared spectroscopy-based computational
model. J. Pharm. Biomed. Anal. 2017, 143, 261–268. [CrossRef]
14. Wang, J.-S.; Shi, J.-S.; Xu, Y.-Z.; Duan, X.-Y.; Zhang, L.; Wang, J.; Yang, L.-M.; Weng, S.-F.; Wu, J.-G. FT-IR
spectroscopic analysis of normal and cancerous tissues of esophagus. World J. Gastroenterol. 2003, 9, 1897–1899.
[CrossRef]
15. Mehrotra, R.; Ray, B.; Chaturvedi, H. Biochemical Characterization of Lung Cancer Tissue: A Spectroscopic
Investigation. J. Cancer Clin. Oncol. 2016, 2, 1–8.
16. Lv, J.; Zhang, L.; Feng, J.; Shi, R. Optical observation of lung cancer with attenuated total reflectance-fourier
transform infrared microscope (ATR-FTIR) and confocal Raman microscope. Spectrosc. Lett. 2011, 44, 312–317.
[CrossRef]
Molecules 2020, 25, 236 13 of 14
17. Kaznowska, E.; Depciuch, J.; Łach, K.; Kołodziej, M.; Koziorowska, A.; Vongsvivut, J.; Zawlik, I.; Cholewa, M.;
Cebulski, J. The classification of lung cancers and their degree of malignancy by FTIR, PCA-LDA analysis,
and a physics-based computational model. Talanta 2018, 186, 337–345. [CrossRef]
18. Lewis, P.D.; Lewis, K.E.; Ghosal, R.; Bayliss, S.; Lloyd, A.J.; Wills, J.; Godfrey, R.; Kloer, P.; Mur, L.A. Evaluation
of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum. Bmc Cancer 2010, 10, 640. [CrossRef]
19. Chrabaszcz, K.; Kochan, K.; Fedorowicz, A.; Jasztal, A.; Buczek, E.; Leslie, L.S.; Bhargava, R.; Malek, K.;
Chlopicki, S.; Marzec, K.M. FT-IR- and Raman-based biochemical profiling of the early stage of pulmonary
metastasis of breast cancer in mice. Analyst 2018, 143, 2042–2050. [CrossRef]
20. Augustyniak, K.; Chrabaszcz, K.; Jasztal, A.; Smeda, M. High and ultra-high definition of infrared spectral
histopathology gives an insight into chemical environment of lung metastases in breast cancer. J. Biophotonics
2019, 12, 201800345. [CrossRef]
21. Blat, A.; Wiercigroch, E.; Smeda, M.; Wislocka, A.; Chlopicki, S.; Malek, K. Fourier transform infrared
spectroscopic signature of blood plasma in the progression of breast cancer with simultaneous metastasis to
lungs. J. Biophotonics 2019, 12, 201900067. [CrossRef]
22. Noreen, R.; Chien, C.C.; Delugin, M.; Yao, S.; Pineau, R.; Hwu, Y.; Moenner, M.; Petibois, C. Detection of
collagens in brain tumors based on FTIR imaging and chemometrics. Anal. Bioanal. Chem. 2011, 401, 845–852.
[CrossRef]
23. Belbachir, K.; Noreen, R.; Gouspillou, G.; Petibois, C. Collagen types analysis and differentiation by FTIR
spectroscopy. Anal. Bioanal. Chem. 2009, 395, 829–837. [CrossRef]
24. Bromberg, P.S.; Gough, K.M.; Dixon, I.M. Collagen remodeling in the extracellular matrix of the
cardiomyopathic Syrian hamster heart as assessed by FTIR attenuated total reflectance spectroscopy.
Can. J. Chem. 1999, 77, 1843–1855. [CrossRef]
25. Varma, V.K.; Kajdacsy-Balla, A.; Akkina, S.; Setty, S.; Walsh, M.J. Predicting Fibrosis Progression in Renal
Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging. Sci. Rep. 2018, 8, 686. [CrossRef]
26. Al-Mehdi, A.B.; Tozawa, K.; Fisher, A.B.; Shientag, L.; Lee, A.; Muschel, R.J. Intravascular origin of metastasis
from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nat. Med. 2000, 6,
100–102. [CrossRef]
27. Bonnans, C.; Chou, J.; Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev.
Mol. Cell Biol. 2014, 15, 786–801. [CrossRef]
28. Gómez-Cuadrado, L.; Tracey, N.; Ma, R.; Qian, B.; Brunton, V.G. Mouse models of metastasis: Progress and
prospects. Dis. Model. Mech. 2017, 10, 1061–1074. [CrossRef]
29. Smeda, M.; Przyborowski, K.; Proniewski, B.; Zakrzewska, A.; Kaczor, D.; Stojak, M.; Buczek, E.; Nieckarz, Z.;
Zoladz, J.A.; Wietrzyk, J.; et al. Breast cancer pulmonary metastasis is increased in mice undertaking
spontaneous physical training in the running wheel; a call for revising beneficial effects of exercise on cancer
progression. Am. J. Cancer Res. 2017, 7, 1926–1936.
30. Smeda, M.; Kieronska, A.; Adamski, M.G.; Proniewski, B.; Sternak, M.; Mohaissen, T.; Przyborowski, K.;
Derszniak, K.; Kaczor, D.; Stojak, M.; et al. Nitric oxide deficiency and endothelial-mesenchymal transition
of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice. Breast Cancer Res. 2018,
20, 86. [CrossRef]
31. Lasch, P. CytospecTM. A Matlab Based Application for Infrared Imaging. 2001. Available online: http:
//www.cytospec.com (accessed on 3 January 2020).
32. Bassan, P.; Kohler, A.; Martens, H.; Lee, J.; Byrne, H.J.; Dumas, P.; Gazi, E.; Brown, M.; Clarke, N.; Gardner, P.
Resonant Mie Scattering (RMieS) correction of infrared spectra from highly scattering biological samples.
Analyst 2010, 135, 268–277. [CrossRef] [PubMed]
33. Smeda, M.; Kieronska, A.; Proniewski, B.; Jasztal, A.; Selmi, A.; Wandzel, K.; Zakrzewska, A.; Wojcik, T.;
Przyborowski, K.; Derszniak, K.; et al. Dual antiplatelet therapy with clopidogrel and aspirin increases
mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour.
Oncotarget 2018, 9, 17810–17824. [CrossRef] [PubMed]
34. Townsley, M.I. Structure and composition of pulmonary arteries, capillaries, and veins. Compr. Physiol. 2012,
2, 675–709. [CrossRef] [PubMed]
35. Pratt, P.C. Basic Anatomy and Histology of the Lung. Toxicol. Ind. Health 1985, 1, 1–5. [CrossRef]
36. Whitsett, J.A.; Alenghat, T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat. Immunol.
2015, 16, 27–35. [CrossRef]
Molecules 2020, 25, 236 14 of 14
37. Federman, S.; Miller, L.M.; Sagi, I. Following matrix metalloproteinases activity near the cell boundary by
infrared micro-spectroscopy. Matrix Biol. 2002, 21, 567–577. [CrossRef]
38. Cheheltani, R.; McGoverin, C.M.; Rao, J.; Vorp, D.A.; Kiani, M.F.; Pleshko, N. Fourier transform infrared
spectroscopy to quantify collagen and elastin in an in vitro model of extracellular matrix degradation in
aorta. Analyst 2014, 139, 3039–3047. [CrossRef]
39. Garlick, P.J.; McNurlan, M.A. Protein metabolism in the cancer patient. Biochimie 1994, 76, 713–717. [CrossRef]
40. Lim, S.; Yoo, B.K.; Kim, H.S.; Gilmore, H.L.; Lee, Y.; Lee, H.P.; Kim, S.J.; Letterio, J.; Lee, H.G. Amyloid-β
precursor protein promotes cell proliferation and motility of advanced breast cancer. BMC Cancer 2014, 14,
1–12. [CrossRef]
41. Audas, T.E.; Audas, D.E.; Jacob, M.D.; Ho, J.J.; Khachi, M.; Wang, M.; Perera, J.K.; Gardiner, C.; Bennett, C.A.;
Head, T.; et al. Adaptation to stressors by systemic protein amyloidogenesis. Dev. Cell 2016, 39, 155–168.
[CrossRef]
42. Mizejewski, G.J. Breast cancer and amyloid bodies: Is there a role for amyloidosis in cancer-cell dormancy?
Breast Cancer Targets 2017, 9, 287–291. [CrossRef]
43. Azzi, S.; Hebda, J.K.; Gavard, J. Vascular permeability and drug delivery in cancers. Front. Oncol. 2013, 3,
211. [CrossRef]
44. Mazur, A.I.; Marcsisin, E.J.; Bird, B.; Milijkovis, M.; Diem, M. Evaluating different fixation protocols for
spectral cytopathology, Part I. Anal. Chem. 2012, 84, 1259–1266. [CrossRef]
45. Verdonck, M.; Wald, N.; Janssis, J.; Yan, P.; Meyer, C.; Legat, A.; Speiser, D.E.; Desmedt, C.; Larsimont, D.;
Sotiriou, C.; et al. Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation
and paraffin-embedding. Analyst 2013, 138, 4083–4091. [CrossRef]
Sample Availability: Samples of the compounds are not available from the authors.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
